ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

ClinicalTrials.gov ID: NCT07042295

Public ClinicalTrials.gov record NCT07042295. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Study of Amivantamab (JNJ-61186372) and Hyaluronidase (rHuPH20) Versus Cetuximab in Immunocompromised Participants With Recurrent Inoperable or Metastatic Cutaneous Squamous Cell Carcinoma

Study identification

NCT ID
NCT07042295
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
86 participants

Conditions and interventions

Interventions

  • Amivantamab and Recombinant Human Hyaluronidase Drug
  • Biospecimen Collection Procedure
  • Cetuximab Biological
  • Computed Tomography Procedure
  • Magnetic Resonance Imaging Procedure

Drug · Procedure · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2026
Primary completion
Feb 27, 2029
Completion
Feb 27, 2029
Last update posted
May 6, 2026

2026 – 2029

United States locations

U.S. sites
31
U.S. states
11
U.S. cities
30
Facility City State ZIP Site status
Banner MD Anderson Cancer Center Gilbert Arizona 85234 Recruiting
UC San Diego Moores Cancer Center La Jolla California 92093 Recruiting
Yale University New Haven Connecticut 06520 Recruiting
Smilow Cancer Hospital Care Center-Trumbull Trumbull Connecticut 06611 Recruiting
Smilow Cancer Hospital Care Center - Waterford Waterford Connecticut 06385 Recruiting
Carle at The Riverfront Danville Illinois 61832 Recruiting
Carle Physician Group-Effingham Effingham Illinois 62401 Recruiting
Carle Physician Group-Mattoon/Charleston Mattoon Illinois 61938 Recruiting
Carle BroMenn Medical Center Normal Illinois 61761 Recruiting
Carle Cancer Institute Normal Normal Illinois 61761 Recruiting
Carle Cancer Center Urbana Illinois 61801 Recruiting
University of Michigan Rogel Cancer Center Ann Arbor Michigan 48109 Recruiting
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 Recruiting
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 Recruiting
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 Recruiting
Memorial Sloan Kettering Commack Commack New York 11725 Recruiting
Memorial Sloan Kettering Westchester Harrison New York 10604 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
Memorial Sloan Kettering Nassau Uniondale New York 11553 Recruiting
UH Seidman Cancer Center at UH Avon Health Center Avon Ohio 44011 Recruiting
UHHS-Chagrin Highlands Medical Center Beachwood Ohio 44122 Recruiting
University of Cincinnati Cancer Center-UC Medical Center Cincinnati Ohio 45219 Recruiting
Case Western Reserve University Cleveland Ohio 44106 Recruiting
University of Cincinnati Cancer Center-West Chester West Chester Ohio 45069 Recruiting
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 Recruiting
M D Anderson Cancer Center Houston Texas 77030 Recruiting
Froedtert Menomonee Falls Hospital Menomonee Falls Wisconsin 53051 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting
Froedtert and MCW Moorland Reserve Health Center New Berlin Wisconsin 53151 Recruiting
Drexel Town Square Health Center Oak Creek Wisconsin 53154 Recruiting
Froedtert West Bend Hospital/Kraemer Cancer Center West Bend Wisconsin 53095 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07042295, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07042295 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →